Biotage AB (publ) (BITGF)
OTCMKTS
· Delayed Price · Currency is USD
14.87
+0.42 (2.91%)
At close: May 23, 2025
Biotage AB Revenue
Biotage AB had revenue of 385.00M SEK in the quarter ending March 31, 2025, a decrease of -19.79%. This brings the company's revenue in the last twelve months to 1.96B, down -1.01% year-over-year. In the year 2024, Biotage AB had annual revenue of 2.06B with 10.42% growth.
Revenue (ttm)
1.96B SEK
Revenue Growth
-1.01%
P/S Ratio
6.14
Revenue / Employee
2.88M SEK
Employees
680
Market Cap
1.20B USD
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.06B | 194.00M | 10.42% |
Dec 31, 2023 | 1.86B | 296.00M | 18.90% |
Dec 31, 2022 | 1.57B | 334.00M | 27.11% |
Dec 31, 2021 | 1.23B | 140.00M | 12.82% |
Dec 31, 2020 | 1.09B | -9.37M | -0.85% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Tian'an Technology Group | 1.78M |
Northwest Biotherapeutics | 1.47M |
Glass House Brands | 215.62M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
Biotage AB News
- 2 months ago - KKR makes $1.2 billion offer for Swedish life-sciences company Biotage - Seeking Alpha
- 2 months ago - KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage - The Wall Street Journal